Singh Priyanka, Vadi Shelvin Kumar, Saikia Uma Nahar, Sood Ashwani, Dahiya Divya, Arya Ashutosh Kumar, Behera Arunanshu, Mukherjee Soham, Arvindkumar Sapara Mohin, Bhadada Sanjay Kumar
Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Clin Endocrinol (Oxf). 2019 Dec;91(6):842-850. doi: 10.1111/cen.14088. Epub 2019 Oct 3.
Minimally invasive parathyroid carcinoma (MIPC) is clinically and biochemically comparable with parathyroid adenoma (PA) though histopathologically differ from PA. MIPC is an intermediate of PA and parathyroid carcinoma (PC). In literature, there is no definite criterion to diagnose MIPC. Our aim was to evaluate and characterize the imaging and biochemical parameters with histological characteristics of MIPC.
Ten patients with MIPC were recruited from (single centre) Indian PHPT registry (www.indianphptregistry.com) from January 2014 to July 2018. Clinical, biochemical, imaging and histological features of MIPC patients were reviewed.
The mean age of MIPC patients (n = 10; 3 males) was 39.9 ± 11.3 years (range: 17-50). All patients had an elevated preoperative parathyroid hormone (iPTH) level ranging from 427 to 2138 pg/mL (median: 1328). MIBI scan showed intensely avid and enlarged parathyroid tumours in all patients; LIPT in 6, RIPT in 3 and ectopic mediastinal in 1 with mean size of the tumours was 2.8 ± 1.1 cm. The mean of maximum standardized uptake value (SUVmax) of MIPC in F-18 fluorocholine PET/CT was 6.7 ± 1.1 (range 6.0-8.3). The mean tumour weight was 12 ± 9.5 g (range: 1.09-28). All MIPC patients had identified capsular invasion in 80% and vascular invasion in 50% only but there was no local invasion, lymph nodal or distant metastasis. The mean Ki-67 labelling index was 3.2 ± 2.7 (range 1.1-10).
The study concluded that MIPC patients are less aggressive (on the basis of imaging and histopathological findings) and should be differentiated from parathyroid adenoma and carcinoma.
微创甲状旁腺癌(MIPC)在临床和生化方面与甲状旁腺腺瘤(PA)相似,但在组织病理学上与PA不同。MIPC是PA和甲状旁腺癌(PC)之间的中间状态。在文献中,尚无诊断MIPC的明确标准。我们的目的是评估和描述MIPC的影像学和生化参数以及组织学特征。
从2014年1月至2018年7月,从(单中心)印度原发性甲状旁腺功能亢进症登记处(www.indianphptregistry.com)招募了10例MIPC患者。回顾了MIPC患者的临床、生化、影像学和组织学特征。
MIPC患者(n = 10;3例男性)的平均年龄为39.9±11.3岁(范围:17 - 50岁)。所有患者术前甲状旁腺激素(iPTH)水平均升高,范围为427至2138 pg/mL(中位数:1328)。MIBI扫描显示所有患者的甲状旁腺肿瘤均有强烈摄取且增大;左侧甲状旁腺肿瘤6例,右侧甲状旁腺肿瘤3例,异位纵隔甲状旁腺肿瘤1例,肿瘤平均大小为2.8±1.1 cm。F - 18氟胆碱PET/CT中MIPC的最大标准化摄取值(SUVmax)平均值为6.7±1.1(范围6.0 - 8.3)。肿瘤平均重量为12±9.5 g(范围:1.09 - 28)。所有MIPC患者中,80%有包膜侵犯,仅50%有血管侵犯,但无局部侵犯、淋巴结转移或远处转移。Ki - 标记指数平均值为3.2±2.7(范围1.1 - 10)。
该研究得出结论,MIPC患者(基于影像学和组织病理学结果)侵袭性较低,应与甲状旁腺腺瘤和癌相鉴别。